Bob Dagher

Directeur Technique/Scientifique/R&D chez BRAINSTORM CELL THERAPEUTICS INC.

Fortune : 123 211 $ au 31/05/2024

55 ans

Health Technology

Consumer Services

Postes actifs de Bob Dagher

Sociétés	Poste	Début	Fin
BRAINSTORM CELL THERAPEUTICS INC.	Directeur Technique/Scientifique/R&D	16/04/2024	-
BRAINSTORM CELL THERAPEUTICS INC.	Corporate Officer/Principal	17/07/2023	16/04/2024

Sociétés	Poste	Début	Fin
ENVERIC BIOSCIENCES, INC.	Directeur Technique/Scientifique/R&D	06/12/2021	01/01/2023
Cadent Therapeutics, Inc. Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	01/12/2019	01/12/2021
COVANCE INC.	Directeur Technique/Scientifique/R&D	01/01/2018	01/01/2019
MedAvante-ProPhase, Inc.	Directeur Technique/Scientifique/R&D	-	-

Université de Bordeaux	Undergraduate Degree
Faculté De Médecine Necker Enfants Malades Université	Undergraduate Degree

Internationale

Etats-Unis	6
France	3

Opérationnelle

Chief Tech/Sci/R&D Officer	4
Corporate Officer/Principal	2
Undergraduate Degree	2

Sectorielle

Health Technology	5
Consumer Services	3

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	2
BRAINSTORM CELL THERAPEUTICS INC.	Health Technology
ENVERIC BIOSCIENCES, INC.	Health Technology

Entreprise privées	3
Labcorp Drug Development, Inc. Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ.	Health Technology
Cadent Therapeutics, Inc. Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA.	Health Technology
MedAvante-ProPhase, Inc.